Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment (Q45859222)
Jump to navigation
Jump to search
scientific article published on 22 June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment |
scientific article published on 22 June 2006 |
Statements
1 reference
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment (English)
1 reference
Stewart DJ
1 reference
Hilton JD
1 reference
Arnold JM
1 reference
Gregoire J
1 reference
Rivard A
1 reference
Archer SL
1 reference
Charbonneau F
1 reference
Cohen E
1 reference
Curtis M
1 reference
Buller CE
1 reference
Mendelsohn FO
1 reference
Dib N
1 reference
Page P
1 reference
Ducas J
1 reference
Plante S
1 reference
Sullivan J
1 reference
Macko J
1 reference
Rasmussen C
1 reference
Kessler PD
1 reference
Rasmussen HS
1 reference
22 June 2006
1 reference
1 reference
13
1 reference
21
1 reference
1503-1511
1 reference
Identifiers
1 reference
1 reference